Abivax
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Values in USD · ADR · Reports in EUR
Abivax
Current Price
$119.90
+5.43%Profile
Valuation (TTM)
Market Cap$8.75B
P/E-22.42
EV—
P/B16.33
Shares Out72.94M
P/Sales1654.10
Revenue$5.29M
EV/EBITDA—
Abivax (ABVX) Stock Analysis
Market Cap$8.75B
Current Price$119.90
P/E Ratio-22.42
Forward P/E—
PEG Ratio-0.36
EPS$-5.68
Book Value$7.34
P/B Ratio16.33
ABVX Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 570M
Revenue
14M
FY21
5M
FY22
5M
FY23
13M
FY24
5M
FY25
Net Income
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
ABVX 52-Week Range
$5.67
$145.31
50-Day MA: $117.40200-Day MA: $107.56
Did you know?
Price sits at 82% of its 52-week range.
Abivax (ABVX) Financial Summary
Abivax (ABVX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. The stock currently trades at $119.90 with a market capitalization of $8.75B.
Key valuation metrics include a P/E ratio of -22.42, price-to-book ratio of 16.33, and EPS of $-5.68. The company reports a profit margin of -7389.6% and return on equity of -73.0%.
ABVX Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $8.75B |
| P/E Ratio | -22.42 |
| EPS | $-5.68 |
| P/B Ratio | 16.33 |
| P/S Ratio | 1654.10 |
| Profit Margin | -7389.6% |
| Return on Equity | -73.0% |
| Debt/Equity | 0.07 |
ABVX Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY21 | $13.59M | $-48.24M |
| FY22 | $4.88M | $-64.62M |
| FY23 | $5.13M | $-164.16M |
| FY24 | $12.97M | $-183.59M |
| FY25 | $5.38M | $-395.41M |
ABVX Quality Indicators
Abivax maintains a profit margin of -7389.6% and an operating margin of -5384.1%. Return on equity stands at -73.0%. The current ratio is 8.75. Debt-to-equity ratio is 0.07.
About Abivax
Abivax
ABVX Free Cash Flow
Abivax generated $-189.73M in trailing twelve-month free cash flow, representing an FCF yield of -2.17%. This low FCF yield may reflect heavy reinvestment or growth spending.
ABVX Shares Outstanding
Abivax has 0.07 billion shares outstanding at a share price of $119.90, giving it a market capitalization of $8.75B.